期刊文献+

钠程序与超滤程序对血液透析中低血压的影响 被引量:2

下载PDF
导出
摘要 随着血液透析技术的不断改进,透析患者老龄化和糖尿病肾病在透析人群中所占比重的不断增长,如何预防透析中低血压的发生,使血液透析能够顺利进行,提高透析患者的生活质量成为一个迫切的问题。本文旨在探讨钠程序与超滤程序对血液透析中低血压的影响,为预防透析中低血压的发生提供临床指导。
出处 《中国血液净化》 2007年第5期276-277,共2页 Chinese Journal of Blood Purification
  • 相关文献

参考文献7

  • 1陈华茜,贾汝汉.透析低血压的发生机制[J].国外医学(泌尿系统分册),2000,20(2):87-89. 被引量:43
  • 2Donauer J,Kolblin D,Bek M,et al.Ultrafiltration profiling and measurement of relative blood volume as strategies to reduce hemodialysis-related side effects[J].Am J Kidney Dis,2000,36:115-123.
  • 3Straver B,Vries PMJM,Donker AJM.The effect of profiled hemodialysis on intradialytic hemodynamias when a proper sodium balance is applled[J].Blood Purif,2002,20:364-369.
  • 4Henrich WL,Woodard TD,Mcpaui JJ.The chronic efficacy and safety of high sodium dialysate:Double blind,crossover study[J].Am J Kidney Dis,1982,2:349-353.
  • 5Sunita D,William L.Preventing dialysis hypotension:A comparison of usual protective maneuvers[J].Kidney Int,2001,59:1175-1181.
  • 6周亦伦,刘惠兰,段晓峰,姚英,孙懿,刘群.钠与超滤模式对血液透析中低血压的作用[J].中华肾脏病杂志,2004,20(1):56-60. 被引量:66
  • 7左力,王梅,魏弘.可调钠透析对维持血容量的作用[J].北京大学学报(医学版),2001,33(4):370-372. 被引量:52

二级参考文献16

  • 1顾鹏飞,张建,仲人前,王爱华.结直肠腺癌患者血清线粒体肌酸激酶检测的意义[J].检验医学,2006,21(2):129-131. 被引量:10
  • 2[1]Petitclerc T, Jxcobs C. Precention of intradialytic morbidity by optimization of dialysate sodium profile [ J ]. Nephrol Dial Transplant, 1995,10(s): 135-140
  • 3[2]Lins LE, Hedenborg G, Jacobson SH, et al. Blood pressure reduction during hemodialysis correlates to intradialytic changes in plasma volume [J], Clinical Nephrol. 1992,37:308-313
  • 4[3]Movilli E, Camerini C, Viola BF, et al. Blood volume changes during three different profiles of dialysate sodium varation with similar intradialytic sodium balances in chronic hemodialyzed patients [J ].Am J Kidney Dis, 1997,30:58-63
  • 5[4]Sadowski RH, Allred EN, Jabs K. Sodium modeling ameliorates intradialytic and interdialytic symptoms in young hemodialysis patients [J]. J Am Soc Nephrol, 1993,4:1192-1198
  • 6[5]Petitclerc T, Trombert JC, Coevoet B, et al. Electrolyte modeling:Sodium. Is dialysate sodium profiling actually useful [ J ] ? Nephrol Dial Transplant, 1996,11(s2) :35-38
  • 7[6]de Vries PMJM, Olthof CG, Schuenemann B, et al. Fluid balance during hemodialysis and hemofiltration: the effect of dialysate sodium and a variable ultrafiltration rate [ J ]. Nephrol Dial Transplant, 1991,6:257-263
  • 8[7]Ebel H, Laage C, Keuchel M, et al. Impact of profile hemodialysis on intra/extracellular fluid shifts and the release of vasoactive hormones in elderly patients on regular dialysis treatment [J]. Nephron, 1997,75:264-271
  • 9陈建芸,石玉玲,李林海,曾兰兰,李晓,何洁静.CK-MB/CK倒置22例CK-MB质量检测结果分析[J].实用医学杂志,2009,25(18):3148-3149. 被引量:8
  • 10吴文礼,邓朝晖,张烨,张艳,鹿新红.血清肌酸激酶同工酶活性大于肌酸激酶活性常见原因分析[J].检验医学与临床,2011,8(18):2262-2263. 被引量:3

共引文献149

同被引文献48

  • 1余金波,邹建洲,刘中华,沈波,徐少伟,滕杰,丁小强.维持性血液透析患者透析中低血压的危险因素研究[J].中国血液净化,2012,11(4):189-193. 被引量:61
  • 2朱月文,周奕菁.糖尿病肾病透析性低血压相关因素分析[J].中国中西医结合肾病杂志,2006,7(1):32-33. 被引量:4
  • 3黄云辉,王丽.不同钠及超滤模式对血液透析患者低血压发生的影响[J].中国血液净化,2006,5(5):286-287. 被引量:6
  • 4Kooman JP, van der Sande FM, Leunissen KM. Role of sodium and volume in the pathogenesis of hypertension in dialysis patients. Reflections on pathophysiological mechanisms. Blood Purif,2004,22 (1) :55 -59.
  • 5Tycho Vuurmans JL, Boer WH, Bos WJ, et al. Contribution of volume overload and angiotensin Ⅱ to the increased pulse wave velocity of hemodialysis patients. J Am Soc Nephrol,2002,13( 1 ) :177 - 183.
  • 6Tripepi G, Mattace-Raso F, Mallamaci F, et al. Biomarkers of left atrial volume:a longitudinal study in patients with end stage renal disease. Hypertension,2009,54(4) :818 - 824.
  • 7Fagugli RM, Pasini P, Quintaliani G, et al. Association between extracellular water, left ventricular mass and hypertension in haemodialysis patients. Nephrol Dial Transplant, 2003,18 ( 11 ) : 2332 2338.
  • 8Stiller S, Bonnie-Schorn E, Grassmann A, et al. A critical review of sodium profiling for hemodialysis. Semin Dial, 2001, 14 ( 5 ) : 337 - 347.
  • 9Lambie SH, Taal MW, Fluck R J, et al. Online conductivity monitoring: validation and usefulness in a clinical trial of reduced dialysate and conductivity. ASAIO J ,2005,51 ( 1 ) :70 -76.
  • 10Davenport A. Audit of the effect of dialysate sodium concentration on interdialytic weight gains and blood pressure control in chronic haemodialysis patients. Nephron Clin Pract, 2006, 104 ( 3 ) : c120 - 125.

引证文献2

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部